Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen.

Future science OA

Khaled HM, Abdelhamid TM, Abu-Taleb FM, El-Hifnawi NM, Waley AB.
PMID: 31608153
Future Sci OA. 2019 Aug 28;5(9):FSO414. doi: 10.2144/fsoa-2019-0076.

AIM & METHODS: To assess the impact of pretreatment serum levels of IL-18 and soluble IL-2 receptor (sIL-2R) on the clinical outcome of patients with diffuse large B-cell lymphoma treated with an R-CHOP protocol. Total 73 patients were included.RESULTS:...

Cite
Khaled HM, Abdelhamid TM, Abu-Taleb FM, et al. Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen. Future Sci OA. 2019;5(9):FSO414doi: 10.2144/fsoa-2019-0076.
Khaled, H. M., Abdelhamid, T. M., Abu-Taleb, F. M., El-Hifnawi, N. M., & Waley, A. B. (2019). Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen. Future science OA, 5(9), FSO414. https://doi.org/10.2144/fsoa-2019-0076
Khaled, Hussein M, et al. "Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen." Future science OA vol. 5,9 (2019): FSO414. doi: https://doi.org/10.2144/fsoa-2019-0076
Khaled HM, Abdelhamid TM, Abu-Taleb FM, El-Hifnawi NM, Waley AB. Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen. Future Sci OA. 2019 Aug 28;5(9):FSO414. doi: 10.2144/fsoa-2019-0076. PMID: 31608153; PMCID: PMC6787521.
Copy Download .nbib Format: NLM
Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India.

Frontiers in oncology

Gogia A, Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S.
PMID: 34926277
Front Oncol. 2021 Dec 02;11:770747. doi: 10.3389/fonc.2021.770747. eCollection 2021.

INTRODUCTION: There is a scarcity of data from India on the impact of cell of origin (COO) on outcomes of diffuse large B-cell lymphoma (DLBCL). This study was conducted to evaluate the impact of COO on outcomes of DLBCL...

Cite
Gogia A, Nair S, Arora S, et al. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021;11:770747doi: 10.3389/fonc.2021.770747.
Gogia, A., Nair, S., Arora, S., Kumar, L., Sharma, A., Gupta, R., Biswas, A., & Mallick, S. (2021). Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Frontiers in oncology, 11770747. https://doi.org/10.3389/fonc.2021.770747
Gogia, Ajay, et al. "Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India." Frontiers in oncology vol. 11 (2021): 770747. doi: https://doi.org/10.3389/fonc.2021.770747
Gogia A, Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021 Dec 02;11:770747. doi: 10.3389/fonc.2021.770747. eCollection 2021. PMID: 34926277; PMCID: PMC8675100.
Copy Download .nbib Format: NLM
Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction.

British journal of neurosurgery

Ponzo G, Umana GE, Valastro M, Giuffrida M, Tranchina MG, Nicoletti GF, Scalia G.
PMID: 33012208
Br J Neurosurg. 2020 Oct 05;1-4. doi: 10.1080/02688697.2020.1828278. Epub 2020 Oct 05.

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) in rare cases can presents an unusual expression of CD3 T-cell specific antigen. We report the first case of a CD3-positive DLBCL of the cervico-thoracic junction presenting with persistent cervical radiculopathy.CASE PRESENTATION: A...

Cite
Ponzo G, Umana GE, Valastro M, et al. Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction. Br J Neurosurg. 2020;1-4doi: 10.1080/02688697.2020.1828278.
Ponzo, G., Umana, G. E., Valastro, M., Giuffrida, M., Tranchina, M. G., Nicoletti, G. F., & Scalia, G. (2020). Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction. British journal of neurosurgery, 1-4. https://doi.org/10.1080/02688697.2020.1828278
Ponzo, Giancarlo, et al. "Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction." British journal of neurosurgery vol. (2020): 1-4. doi: https://doi.org/10.1080/02688697.2020.1828278
Ponzo G, Umana GE, Valastro M, Giuffrida M, Tranchina MG, Nicoletti GF, Scalia G. Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction. Br J Neurosurg. 2020 Oct 05;1-4. doi: 10.1080/02688697.2020.1828278. Epub 2020 Oct 05. PMID: 33012208.
Copy Download .nbib Format: NLM
Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature.

World journal of clinical cases

Gładyś A, Kozak S, Wdowiak K, Winder M, Chudek J.
PMID: 33553416
World J Clin Cases. 2021 Jan 26;9(3):748-757. doi: 10.12998/wjcc.v9.i3.748.

BACKGROUND: Post-transplant lymphoproliferative disease (PTLD) is a heterogeneous group of diseases that develop after solid organ and hematopoietic stem cells transplantation related to intensive immunosuppression regimen, T-cell depletion and Epstein-Barr virus infection. Despite the improvement in the management of...

Cite
Gładyś A, Kozak S, Wdowiak K, et al. Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature. World J Clin Cases. 2021;9(3):748-757doi: 10.12998/wjcc.v9.i3.748.
Gładyś, A., Kozak, S., Wdowiak, K., Winder, M., & Chudek, J. (2021). Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature. World journal of clinical cases, 9(3), 748-757. https://doi.org/10.12998/wjcc.v9.i3.748
Gładyś, Aleksandra, et al. "Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature." World journal of clinical cases vol. 9,3 (2021): 748-757. doi: https://doi.org/10.12998/wjcc.v9.i3.748
Gładyś A, Kozak S, Wdowiak K, Winder M, Chudek J. Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature. World J Clin Cases. 2021 Jan 26;9(3):748-757. doi: 10.12998/wjcc.v9.i3.748. PMID: 33553416; PMCID: PMC7829726.
Copy Download .nbib Format: NLM
Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India.

Frontiers in oncology

Gogia A, Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S.
PMID: 34926277
Front Oncol. 2021 Dec 02;11:770747. doi: 10.3389/fonc.2021.770747. eCollection 2021.

INTRODUCTION: There is a scarcity of data from India on the impact of cell of origin (COO) on outcomes of diffuse large B-cell lymphoma (DLBCL). This study was conducted to evaluate the impact of COO on outcomes of DLBCL...

Cite
Gogia A, Nair S, Arora S, et al. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021;11:770747doi: 10.3389/fonc.2021.770747.
Gogia, A., Nair, S., Arora, S., Kumar, L., Sharma, A., Gupta, R., Biswas, A., & Mallick, S. (2021). Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Frontiers in oncology, 11770747. https://doi.org/10.3389/fonc.2021.770747
Gogia, Ajay, et al. "Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India." Frontiers in oncology vol. 11 (2021): 770747. doi: https://doi.org/10.3389/fonc.2021.770747
Gogia A, Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021 Dec 02;11:770747. doi: 10.3389/fonc.2021.770747. eCollection 2021. PMID: 34926277; PMCID: PMC8675100.
Copy Download .nbib Format: NLM
Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Arslan SH, Uyetürk U, Tekgündüz E, Irkkan SÇ, Kurt MY, Demiriz IŞ, Altuntaş F.
PMID: 24744673
Turk J Haematol. 2012 Sep;29(3):274-7. doi: 10.5152/tjh.2011.80. Epub 2012 Oct 05.

Primary non-Hodgkin's lymphoma (NHL) of the breast constitutes 0.04%-0.53% of all malignancies and 2.2% of extra nodal lymphomas. In total, 7%-8% of all B-cell lymphomas are the mucosa-associated lymphoid tissue (MALT) type, of which up to 50% of primary...

Cite
Arslan SH, Uyetürk U, Tekgündüz E, et al. Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report. Turk J Haematol. 2012;29(3):274-7doi: 10.5152/tjh.2011.80.
Arslan, S. H., Uyetürk, U., Tekgündüz, E., Irkkan, S. �. �., Kurt, M. Y., Demiriz, I. �. �., & Altuntaş, F. (2012). Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report. Turkish journal of haematology : official journal of Turkish Society of Haematology, 29(3), 274-7. https://doi.org/10.5152/tjh.2011.80
Arslan, Serife Hülya, et al. "Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report." Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 29,3 (2012): 274-7. doi: https://doi.org/10.5152/tjh.2011.80
Arslan SH, Uyetürk U, Tekgündüz E, Irkkan SÇ, Kurt MY, Demiriz IŞ, Altuntaş F. Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report. Turk J Haematol. 2012 Sep;29(3):274-7. doi: 10.5152/tjh.2011.80. Epub 2012 Oct 05. PMID: 24744673; PMCID: PMC3986754.
Copy Download .nbib Format: NLM
Aggressive Lymphoma "Sarcoma Mimicker" Originating in the Gluteus and Adductor Muscles: A Case Report and Literature Review.

Clinical medicine insights. Case reports

Elkourashy SA, Nashwan AJ, Alam SI, Ammar AA, El Sayed AM, Omri HE, Yassin MA.
PMID: 27398038
Clin Med Insights Case Rep. 2016 Jul 05;9:47-53. doi: 10.4137/CCRep.S39052. eCollection 2016.

Extranodal lymphoma (ENL) occurs in approximately 30%-40% of all patients with non-Hodgkin lymphoma and has been described in almost all organs and tissues. However, diffuse large B-cell lymphoma is the most common histological subtype of non-Hodgkin lymphoma, primarily arising...

Cite
Elkourashy SA, Nashwan AJ, Alam SI, et al. Aggressive Lymphoma "Sarcoma Mimicker" Originating in the Gluteus and Adductor Muscles: A Case Report and Literature Review. Clin Med Insights Case Rep. 2016;9:47-53doi: 10.4137/CCRep.S39052.
Elkourashy, S. A., Nashwan, A. J., Alam, S. I., Ammar, A. A., El Sayed, A. M., Omri, H. E., & Yassin, M. A. (2016). Aggressive Lymphoma "Sarcoma Mimicker" Originating in the Gluteus and Adductor Muscles: A Case Report and Literature Review. Clinical medicine insights. Case reports, 947-53. https://doi.org/10.4137/CCRep.S39052
Elkourashy, Sarah A, et al. "Aggressive Lymphoma "Sarcoma Mimicker" Originating in the Gluteus and Adductor Muscles: A Case Report and Literature Review." Clinical medicine insights. Case reports vol. 9 (2016): 47-53. doi: https://doi.org/10.4137/CCRep.S39052
Elkourashy SA, Nashwan AJ, Alam SI, Ammar AA, El Sayed AM, Omri HE, Yassin MA. Aggressive Lymphoma "Sarcoma Mimicker" Originating in the Gluteus and Adductor Muscles: A Case Report and Literature Review. Clin Med Insights Case Rep. 2016 Jul 05;9:47-53. doi: 10.4137/CCRep.S39052. eCollection 2016. PMID: 27398038; PMCID: PMC4934407.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries